ClinicalTrials.Veeva

Menu

Economic Analysis of Robotic Rectal Resection in German Health Care System

U

Universitätsklinikum Hamburg-Eppendorf

Status

Completed

Conditions

Rectal Cancer

Treatments

Other: Surgery

Study type

Observational

Funder types

Other

Identifiers

NCT06113796
UKE Hamburg 3

Details and patient eligibility

About

Analysis of cost effectiveness of robotic rectal resection, either sphincter preserving or abdominoperineal extirpation, in the German diagnosis related groups (DRG) system.

Full description

Robotic surgery has many well-known benefits for patients and surgeons, while it comes with higher acquisition and maintenance costs. On the other hand, a higher proportion of minimally invasive procedures can save costs by reducing complications, decreasing hospital stays due to lower morbidity, and saving personnel.

To what extent can robotic surgery be cost-covering or even profitable, depending on the postoperative course? This question is investigated under the conditions of the German DRG system.

Enrollment

65 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18y
  • histologically proven rectal cancer with curative therapeutic approach
  • suitable for minimally-invasive surgery

Exclusion criteria

  • no rectal cancer
  • primary open surgery

Trial design

65 participants in 2 patient groups

Robotic sphincter-preserving rectal resection
Description:
Patients with robotic anterior or low anterior rectal resection and primary anastomosis for rectal cancer.
Treatment:
Other: Surgery
Robotic abdominoperineal rectal resection
Description:
Patients with robotic abdominoperineal rectal resection for rectal cancer.
Treatment:
Other: Surgery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems